12 | VCEX going big time here! | prislea | 07/10/2019 6:29:50 AM |
11 | Shit stock with no updates after symbol | pennystockpro32 | 02/07/2019 12:17:30 PM |
10 | Stock is still trash!! No update from | pennystockpro32 | 09/20/2018 5:23:44 PM |
9 | This just popped up | HoppinGator | 03/12/2018 8:51:29 PM |
8 | Absolutely NOTHING was missed | pennystockpro32 | 02/08/2018 4:16:59 PM |
7 | $FVRD undervaled here IMO. should be over | I Need Money | 01/15/2018 7:54:06 AM |
6 | Don't miss this one guys. | vantillian | 12/10/2017 10:11:22 PM |
5 | This fraudulent CE slapped on by the OTC is | Dmwcrash | 12/05/2017 8:32:35 AM |
4 | very nice. congrats. | joey68 | 11/27/2017 11:58:56 PM |
3 | FVRD taking off big time here. | SOLO420 | 10/23/2017 2:44:59 PM |
2 | FVRD 0.01 Stock Charts $FVRD 1 Month Chart | chartguy89 | 03/07/2014 9:17:49 AM |
1 | FVRD Stock Charts Last: -0.005 Wednesday, | chartguy89 | 02/26/2014 8:23:35 AM |
Recent Articles
- ICG Enterprise Trust Announces Share Buyback Activities
- GXO and B&Q Forge Path Towards Carbon-Neutral Logistics Goals
- Revolutionizing AI Safety in Vehicle-Mounted Computing Solutions
- Nanobiotix's Voting Rights and Share Capital Explained
- IMCD Expands Its Market Reach with Strategic Tillmanns Acquisition
- OpenAI Faces Legal Action Over ChatGPT's Troubling Role in Teen's Death
- Titan Pharmaceuticals' Major Merger Fuels Stock Growth
- KuCoin Champions Thailand’s G-Token Initiative to Innovate Finance
- D-Link Introduces Advanced 2.5G Switches for Modern Networks
- Keymed Biosciences Achieves Groundbreaking Results for 2025
- Sydbank's Impressive H1 2025 Performance Despite Challenges
- Tesla's Ambitious Expansion Of Robotaxi Services In Austin
- Ageas Achieves Impressive First Half-Year Results for 2025
- Capital Shift: BitMine's Impact on BTC and ETH Investments
- Ageas Elevates Financial Targets Following Impressive Results
- Sampo plc's Strategic Share Buyback Highlights and Insights
- FLSmidth's Strategic Share Buy-Back Program Update
- Oncoinvent ASA: Advancing Cancer Therapies with Financial Focus
- XRP Healthcare Unveils Revolutionary HIPAA-Compliant App in Africa
- Oncoinvent ASA: Progress in Cancer Treatment and Cost Reduction
- Oncoinvent ASA Reports Financial Progress and Clinical Advancements
- KONE Partners with United Elevators to Enhance Mobility Solutions
- Vivoryon Therapeutics N.V. Announces Upcoming Financial Report
- Meta's Hypernova Glasses: A Bold but Cautious Move Forward
- Bigbank AS Streamlines Operations Through Merger Announcement
- Idorsia Revamps Convertible Bonds for Future Growth
- Vivoryon Therapeutics N.V. Prepares for H1 2025 Results Release
- IDEX Biometrics ASA Delivers Impressive Cost Savings in 2025
- NovaBay Pharmaceuticals Reports Record Surge After Dividend News
- Exciting Developments in Quantum Technology at Q2B Paris Event
- SpaceX Achieves Breakthrough with Starship's Latest Launch Test
- HiTHIUM Unveils Groundbreaking Energy Storage Project in Saudi Arabia
- Strengthening Ties: Xi Jinping's Meeting with Duma Chairman
- Trump Media's Bold Move Boosts CRO Token Value Remarkably
- Social Security Recipients Face Tariff-Induced Inflation Fears
- Discover Innovations in Manufacturing at UK Metals Expo 2025
- Nvidia Unveils New Robotics Standard with Jetson AGX Thor Chip
- Peter Schiff's Concerns Over Bitcoin's Future Amidst Market Shift
- AIMA Technology's BIG SUR Series Triumphs at International Awards
- AIMA's Santa Monica E-Bike Earns Recognition at DNA Design Awards
- Discover Why Optimized Air is the Go-To HVAC Company Today
- JOYY's Impressive Q2 2025 Earnings Showcase Diverse Growth
- JOYY Inc. Reports Strong Q2 2025 Results with Revenue Advances
- Cracker Barrel’s Stock Surge: The Logo Comeback and Impact
- Transforming Meter Reading: CHINT's Smart Solutions for Islands
- Immuron and InvestorHub Forge New Investor Engagement Path
- Junshi Biosciences Reports 2025 Interim Financial Results
- Mike Pence Critiques Trump's Intel Stake, Defends Free Markets
- Cryptocurrency Market Sees Major Gains Amid Fed Developments
- Junshi Biosciences' 2025 Interim Financial Performance Revealed